RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Telcon RF Pharmaceutical Stock

Telcon RF Pharmaceutical ROA 2025

Telcon RF Pharmaceutical ROA

0.1

Ticker

200230.KQ

ISIN

KR7200230001

In 2025, Telcon RF Pharmaceutical's return on assets (ROA) was 0.1, a -128.06% increase from the -0.35 ROA in the previous year.

Telcon RF Pharmaceutical Aktienanalyse

What does Telcon RF Pharmaceutical do?

Telcon RF Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Telcon RF Pharmaceutical's Return on Assets (ROA)

Telcon RF Pharmaceutical's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Telcon RF Pharmaceutical's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Telcon RF Pharmaceutical's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Telcon RF Pharmaceutical’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Telcon RF Pharmaceutical stock

What is the Return on Assets (ROA) of Telcon RF Pharmaceutical this year?

The Return on Assets (ROA) of Telcon RF Pharmaceutical is 0.1 undefined this year.

What was the ROA of Telcon RF Pharmaceutical compared to the previous year?

The ROA of Telcon RF Pharmaceutical has increased by -128.06% compared to the previous year.

What consequences do high ROA have for investors of Telcon RF Pharmaceutical?

A high ROA is advantageous for investors of Telcon RF Pharmaceutical, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Telcon RF Pharmaceutical?

A low ROA can be unfavorable for investors of Telcon RF Pharmaceutical as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Telcon RF Pharmaceutical affect the company?

An increase in ROA of Telcon RF Pharmaceutical can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Telcon RF Pharmaceutical impact the company?

A reduction in the ROA of Telcon RF Pharmaceutical can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Telcon RF Pharmaceutical?

Some factors that can influence the ROA of Telcon RF Pharmaceutical include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Telcon RF Pharmaceutical important for investors?

The ROA of Telcon RF Pharmaceutical is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Telcon RF Pharmaceutical take to improve ROA?

To improve ROA, Telcon RF Pharmaceutical can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Telcon RF Pharmaceutical pay?

Over the past 12 months, Telcon RF Pharmaceutical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Telcon RF Pharmaceutical is expected to pay a dividend of 0 KRW.

What is the dividend yield of Telcon RF Pharmaceutical?

The current dividend yield of Telcon RF Pharmaceutical is .

When does Telcon RF Pharmaceutical pay dividends?

Telcon RF Pharmaceutical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Telcon RF Pharmaceutical?

Telcon RF Pharmaceutical paid dividends every year for the past 0 years.

What is the dividend of Telcon RF Pharmaceutical?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Telcon RF Pharmaceutical located?

Telcon RF Pharmaceutical is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von Telcon RF Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Telcon RF Pharmaceutical from 2/7/2025 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 2/7/2025.

When did Telcon RF Pharmaceutical pay the last dividend?

The last dividend was paid out on 2/7/2025.

What was the dividend of Telcon RF Pharmaceutical in the year 2024?

In the year 2024, Telcon RF Pharmaceutical distributed 0 KRW as dividends.

In which currency does Telcon RF Pharmaceutical pay out the dividend?

The dividends of Telcon RF Pharmaceutical are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Telcon RF Pharmaceutical

Our stock analysis for Telcon RF Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Telcon RF Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.